TTY Biopharm Valuation
| 4105 Stock | TWD 74.00 0.40 0.54% |
At this time, the company appears to be fairly valued. TTY Biopharm has a current Real Value of NT$73.85 per share. The regular price of the company is NT$74.0. Our model measures the value of TTY Biopharm from inspecting the company fundamentals such as Return On Equity of 0.21, operating margin of 0.26 %, and Shares Outstanding of 248.65 M as well as reviewing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that TTY Biopharm's price fluctuation is very steady at this time. Calculation of the real value of TTY Biopharm is based on 3 months time horizon. Increasing TTY Biopharm's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the TTY stock is determined by what a typical buyer is willing to pay for full or partial control of TTY Biopharm Co. Since TTY Biopharm is currently traded on the exchange, buyers and sellers on that exchange determine the market value of TTY Stock. However, TTY Biopharm's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 74.0 | Real 73.85 | Hype 74.0 | Naive 74.24 |
The intrinsic value of TTY Biopharm's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence TTY Biopharm's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of TTY Biopharm Co helps investors to forecast how TTY stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of TTY Biopharm more accurately as focusing exclusively on TTY Biopharm's fundamentals will not take into account other important factors: TTY Biopharm Total Value Analysis
TTY Biopharm Co is presently anticipated to have takeover price of 20.05 B with market capitalization of 19.37 B, debt of 4.15 M, and cash on hands of 2.89 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the TTY Biopharm fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
20.05 B | 19.37 B | 4.15 M | 2.89 B |
TTY Biopharm Investor Information
About 21.0% of the company shares are owned by insiders or employees . The book value of TTY Biopharm was presently reported as 21.97. The company last dividend was issued on the 19th of July 2022. TTY Biopharm had 1067:1000 split on the 13th of August 2014. Based on the analysis of TTY Biopharm's profitability, liquidity, and operating efficiency, TTY Biopharm Co is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.TTY Biopharm Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. TTY Biopharm has an asset utilization ratio of 48.79 percent. This indicates that the Company is making NT$0.49 for each dollar of assets. An increasing asset utilization means that TTY Biopharm Co is more efficient with each dollar of assets it utilizes for everyday operations.TTY Biopharm Ownership Allocation
TTY Biopharm shows a total of 248.65 Million outstanding shares. TTY Biopharm maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.TTY Biopharm Profitability Analysis
The company reported the revenue of 4.54 B. Net Income was 831.89 M with profit before overhead, payroll, taxes, and interest of 2.77 B.About TTY Biopharm Valuation
Our relative valuation model uses a comparative analysis of TTY Biopharm. We calculate exposure to TTY Biopharm's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of TTY Biopharm's related companies.TTY Biopharm Company Limited, together with its subsidiaries, produces various pharmaceuticals and chemical drugs in Taiwan and internationally. The company was founded in 1960 and is headquartered in Taipei City, Taiwan. TTY BIOPHARM is traded on Taiwan OTC Exchange in Taiwan.
8 Steps to conduct TTY Biopharm's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates TTY Biopharm's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct TTY Biopharm's valuation analysis, follow these 8 steps:- Gather financial information: Obtain TTY Biopharm's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine TTY Biopharm's revenue streams: Identify TTY Biopharm's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research TTY Biopharm's industry and market trends, including the size of the market, growth rate, and competition.
- Establish TTY Biopharm's growth potential: Evaluate TTY Biopharm's management, business model, and growth potential.
- Determine TTY Biopharm's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate TTY Biopharm's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for TTY Stock Analysis
When running TTY Biopharm's price analysis, check to measure TTY Biopharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TTY Biopharm is operating at the current time. Most of TTY Biopharm's value examination focuses on studying past and present price action to predict the probability of TTY Biopharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TTY Biopharm's price. Additionally, you may evaluate how the addition of TTY Biopharm to your portfolios can decrease your overall portfolio volatility.